precision medicine

R&D

Built for one: The case for custom formulation in the era of...

The precision medicine market is projected to exceed $175 billion by 2030, reflecting continued growth and interest in innovative approaches that tailor therapeutics that accounts for diffe

Oncology

AACR 2025: New modalities and remaining challenges

Explore the latest advancements and challenges in ADC therapy at AACR 2025: New modalities and remaining challenges

Oncology

A quarter of cancer patients don’t respond to targeted thera...

The more progress we make in precision medicine, the more edge cases we discover.

R&D

The irony of data in precision medicine: Igniting progress w...

As I regularly engage with pharma executives and biotech founders, a common theme inevitably arises: why is precision medicine taking so long to become a reality, and is technology to blame

Digital

Balancing innovation and efficiency in clinical trials: Is t...

Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes

R&D

The role of bioanalysis as the foundation of precision medic...

Precision medicine, also known as personalised medicine, is transforming healthcare by providing tailored treatments to patients suffering from life-threatening conditions.